238 related articles for article (PubMed ID: 23386426)
1. Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies.
Ried M; Potzger T; Braune N; Diez C; Neu R; Sziklavari Z; Schalke B; Hofmann HS
J Surg Oncol; 2013 Jun; 107(7):735-40. PubMed ID: 23386426
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
3. [Radical pleurectomy and hyperthermic intrathoracic chemotherapy for treatment of thymoma with pleural spread].
Ried M; Neu R; Schalke B; Sziklavari Z; Hofmann HS
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S52-7. PubMed ID: 24150857
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma.
van Ruth S; van Tellingen O; Korse CM; Verwaal VJ; Zoetmulder FA
Anticancer Drugs; 2003 Jan; 14(1):57-65. PubMed ID: 12544259
[TBL] [Abstract][Full Text] [Related]
5. Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy†.
Ambrogi MC; Korasidis S; Lucchi M; Fanucchi O; Giarratana S; Melfi F; Mussi A
Eur J Cardiothorac Surg; 2016 Jan; 49(1):321-6. PubMed ID: 25666471
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
7. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
8. [Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion].
Hofmann HS; Wiebe K
Chirurg; 2010 Jun; 81(6):557-62. PubMed ID: 20454769
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
10. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.
Ratto GB; Civalleri D; Esposito M; Spessa E; Alloisio A; De Cian F; Vannozzi MO
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):759-65. PubMed ID: 10096972
[TBL] [Abstract][Full Text] [Related]
11. Reoperation combined with intraoperative hyperthermic intrathoracic perfusion chemotherapy for pleural recurrence of thymoma.
de Bree E; van Ruth S; Rutgers EJ; Zoetmulder FA
J Surg Oncol; 2002 Aug; 80(4):224-5. PubMed ID: 12210039
[No Abstract] [Full Text] [Related]
12. Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread.
Refaely Y; Simansky DA; Paley M; Gottfried M; Yellin A
Ann Thorac Surg; 2001 Aug; 72(2):366-70. PubMed ID: 11515868
[TBL] [Abstract][Full Text] [Related]
13. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
[TBL] [Abstract][Full Text] [Related]
15. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
[TBL] [Abstract][Full Text] [Related]
16. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
[TBL] [Abstract][Full Text] [Related]
17. A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma.
Shimokawa M; Hasegawa S; Fukuoka K; Okada M; Yokoi K; Tanaka F; Yamanaka T; Daimon T; Nakano T
Jpn J Clin Oncol; 2013 May; 43(5):575-8. PubMed ID: 23509402
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.
Ried M; Lehle K; Neu R; Diez C; Bednarski P; Sziklavari Z; Hofmann HS
Eur J Cardiothorac Surg; 2015 Mar; 47(3):563-6. PubMed ID: 24872472
[TBL] [Abstract][Full Text] [Related]
20. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
